Related Experiment Video
Updated: Nov 1, 2025

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
3.7K
Hypersensitivity reactions to biologicals: An EAACI position paper
Sevim Bavbek1, Mauro Pagani2, Emilio Alvarez-Cuesta3
1Division of Immunology and Allergy, Department of Chest Diseases, School of Medicine, Ankara University, Ankara, Turkey.
Allergy
|June 22, 2021
Summary
Biologicals, crucial for treating cancer and immune diseases, frequently cause hypersensitivity reactions (HSRs). This paper offers evidence-based guidance for diagnosing and managing these potentially severe HSRs to biological therapies.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Biological therapies are increasingly used for oncological, immunological, and inflammatory conditions.
- Personalized Precision Medicine has accelerated the development and use of biologicals.
- Biologicals are now a common cause of hypersensitivity reactions (HSRs), which can be severe.
Purpose of the Study:
- To provide evidence-based recommendations for the diagnosis and management of HSRs to biologicals.
- To define unmet needs in the field of HSRs to biologicals to guide future research.
Main Methods:
- This Position Paper synthesizes current evidence.
- Expert consensus and literature review inform the recommendations.
Main Results:
- HSRs to biologicals can occur upon first or repeated exposure.
- Mechanisms underlying HSRs to biologicals are not fully understood.
- Optimal management strategies for HSRs to biologicals are still debated.
Conclusions:
- Clear diagnostic and management guidelines are needed for HSRs to biologicals.
- Further research is required to elucidate HSR mechanisms and improve patient outcomes.
Related Concept Videos
Allergic Drug Reactions
1.1K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.1K
Hypersensitivities
3.1K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
3.1K
Allergic Reactions
29.4K
Overview
29.4K
Cross-reactivity
31.9K
Overview
31.9K
Antibody Structure
62.1K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
62.1K
Enzyme-Linked Immunosorbent Assay
15.2K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
15.2K

